MannKind Corporation
NASDAQ:
MNKD
MannKind Corporation is a biopharmaceutical company focused on developing and commercializing therapeutics for endocrine and orphan lung diseases. Headquartered in Danbury, Connecticut, and founded in 1991, its products include Afrezza, an inhaled insulin fo
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
US Equity Report
A$5000.00
Already a subscriber?
Sign in to read this report.
Required subscription
US Equity Report
Expand beyond the ASX with expert research on carefully selected U.S. stocks, covering market leaders, emerging opportunities, and global investment trends.
- ✓ U.S. Stock Research & Analysis
- ✓ Delivered every Friday
- ✓ Company & Industry Analysis
- ✓ Full Historical Report Access
A$5000.00/ 12 months
Risk:Medium
Subscribe Now →
